Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J. Paesmans M, et al. Among authors: sergysels r. Cancer. 2000 Aug 1;89(3):523-33. doi: 10.1002/1097-0142(20000801)89:3<523::aid-cncr7>3.0.co;2-6. Cancer. 2000. PMID: 10931451
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, et al. Paesmans M, et al. Among authors: sergysels r. J Clin Oncol. 1995 May;13(5):1221-30. doi: 10.1200/JCO.1995.13.5.1221. J Clin Oncol. 1995. PMID: 7738625 Clinical Trial.
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Klastersky J, Giner V, Bureau G, Thiriaux J, Dabouis G, Efremidis A, Ries F, Berchier MC, Sergysels R, et al. Sculier JP, et al. Among authors: sergysels r. J Clin Oncol. 1994 Feb;12(2):353-9. doi: 10.1200/JCO.1994.12.2.353. J Clin Oncol. 1994. PMID: 8113843 Clinical Trial.
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Bureau G, Giner V, Lecomte J, Michel J, Berchier MC, Van Cutsem O, Küstner U, Kroll F, Sergysels R, Mommen P, Klastersky J. Sculier JP, et al. Among authors: sergysels r. J Clin Oncol. 1996 Aug;14(8):2337-44. doi: 10.1200/JCO.1996.14.8.2337. J Clin Oncol. 1996. PMID: 8708726 Clinical Trial.
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Borges M, Sculier JP, Paesmans M, Richez M, Bureau G, Dabouis G, Lecomte J, Michel J, Van Cutsem O, Schmerber J, Giner V, Berchier MC, Sergysels R, Mommen P, Klastersky J. Borges M, et al. Among authors: sergysels r. Lung Cancer. 1996 Dec;16(1):21-33. doi: 10.1016/s0169-5002(96)00609-5. Lung Cancer. 1996. PMID: 9017582
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, Klastersky J. Paesmans M, et al. Among authors: sergysels r. Eur J Cancer. 1997 Dec;33(14):2326-32. doi: 10.1016/s0959-8049(97)00325-0. Eur J Cancer. 1997. PMID: 9616276
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer.
Sculier J, Thiriaux J, Bureau G, Lafitte J, Recloux P, Brohee D, Berchier M, Sergysels R, Mommen P, Paesmans M, Klastersky J, Lecomte J, Vanschaardenburg C, Richard V, Diana D, Fortin F, Tagnon A, Kustner U. Sculier J, et al. Among authors: sergysels r. Int J Oncol. 1995 Feb;6(2):425-9. doi: 10.3892/ijo.6.2.425. Int J Oncol. 1995. PMID: 21556555
161 results